» Articles » PMID: 38217649

Ribosome Profiling Methods Adapted to the Study of RNA-Dependent Translation Regulation in Staphylococcus Aureus

Overview
Specialty Molecular Biology
Date 2024 Jan 13
PMID 38217649
Authors
Affiliations
Soon will be listed here.
Abstract

Noncoding RNAs, including regulatory RNAs (sRNAs), are instrumental in regulating gene expression in pathogenic bacteria, allowing them to adapt to various stresses encountered in their host environments. Staphylococcus aureus is a well-studied model for RNA-mediated regulation of virulence and pathogenicity, with sRNAs playing significant roles in shaping S. aureus interactions with human and animal hosts. By modulating the translation and/or stability of target mRNAs, sRNAs regulate the synthesis of virulence factors and regulatory proteins required for pathogenesis. Moreover, perturbation of the levels of RNA modifications in two other classes of noncoding RNAs, rRNAs, and tRNAs, has been proposed to contribute to stress adaptation. However, the study of how these various factors affect translation regulation has often been restricted to specific genes, using in vivo reporters and/or in vitro translation systems. Genome-wide sequencing approaches offer novel perspectives for studying RNA-dependent regulation. In particular, ribosome profiling methods provide a powerful resource for characterizing the overall landscape of translational regulation, contributing to a better understanding of S. aureus physiopathology. Here, we describe protocols that we have adapted to perform ribosome profiling in S. aureus.

Citing Articles

Bacterial Metallostasis: Metal Sensing, Metalloproteome Remodeling, and Metal Trafficking.

Capdevila D, Rondon J, Edmonds K, Rocchio J, Villarruel Dujovne M, Giedroc D Chem Rev. 2024; 124(24):13574-13659.

PMID: 39658019 PMC: 11672702. DOI: 10.1021/acs.chemrev.4c00264.

References
1.
Cheung G, Bae J, Otto M . Pathogenicity and virulence of . Virulence. 2021; 12(1):547-569. PMC: 7872022. DOI: 10.1080/21505594.2021.1878688. View

2.
Tong S, Davis J, Eichenberger E, Holland T, Fowler Jr V . Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015; 28(3):603-61. PMC: 4451395. DOI: 10.1128/CMR.00134-14. View

3.
Stryjewski M, Corey G . Methicillin-resistant Staphylococcus aureus: an evolving pathogen. Clin Infect Dis. 2013; 58 Suppl 1:S10-9. DOI: 10.1093/cid/cit613. View

4.
Howden B, Davies J, Johnson P, Stinear T, Grayson M . Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev. 2010; 23(1):99-139. PMC: 2806658. DOI: 10.1128/CMR.00042-09. View

5.
Wu Q, Sabokroo N, Wang Y, Hashemian M, Karamollahi S, Kouhsari E . Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates. Antimicrob Resist Infect Control. 2021; 10(1):101. PMC: 8247230. DOI: 10.1186/s13756-021-00967-y. View